Stereotactic body radiotherapy plus pembrolizumab and trametinib for pancreatic cancer.

Okano, Naohiro; Mizutani, Tomonori; Nagashima, Fumio; Furuse, Junji

Okano, Naohiro; Mizutani, Tomonori; Nagashima, Fumio; Furuse, Junji.

Afiliação

Okano N; Department of Medical Oncology, Kyorin University Faculty of Medicine, Mitaka, Tokyo 181-8611, Japan. Electronic address: naohiro-okano@ks.kyorin-u.ac.jp.
Mizutani T; Department of Medical Oncology, Kyorin University Faculty of Medicine, Mitaka, Tokyo 181-8611, Japan.
Nagashima F; Department of Medical Oncology, Kyorin University Faculty of Medicine, Mitaka, Tokyo 181-8611, Japan.
Furuse J; Department of Medical Oncology, Kyorin University Faculty of Medicine, Mitaka, Tokyo 181-8611, Japan.

Lancet Oncol ; 22(10): e423, 2021 10.

Article em En | MEDLINE | ID: mdl-34592184

Assuntos

Neoplasias Pancreáticas; Radiocirurgia; Anticorpos Monoclonais Humanizados/efeitos adversos; Humanos; Neoplasias Pancreáticas/tratamento farmacológico; Piridonas; Pirimidinonas; Radiocirurgia/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Pancreáticas / Radiocirurgia Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google